Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis
Kai Wei Lee, Sook Fan Yap, Yun Fong Ngeow, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 7, pp. 3554-3554
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study
Waasila Jassat, Cheryl Cohen, Stefano Tempia, et al.
The Lancet HIV (2021) Vol. 8, Iss. 9, pp. e554-e567
Open Access | Times Cited: 154
Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis
Célestin Danwang, Jean Jacques Noubiap, Annie Robert, et al.
AIDS Research and Therapy (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 104
HIV and COVID-19: review of clinical course and outcomes
Lauren K. Barbera, Kevin Kamis, Sarah E. Rowan, et al.
HIV Research & Clinical Practice (2021) Vol. 22, Iss. 4, pp. 102-118
Open Access | Times Cited: 63
Trends in COVID-19 admissions and deaths among people living with HIV in South Africa: analysis of national surveillance data
Waasila Jassat, Caroline Mudara, Lovelyn Ozougwu, et al.
The Lancet HIV (2024) Vol. 11, Iss. 2, pp. e96-e105
Closed Access | Times Cited: 7
Global and Regional Prevalence and Outcomes of COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis
Tope Oyelade, Jaber S. Alqahtani, Ahmed Hjazi, et al.
Tropical Medicine and Infectious Disease (2022) Vol. 7, Iss. 2, pp. 22-22
Open Access | Times Cited: 35
Risk of mortality in HIV-infected COVID-19 patients: A systematic review and meta-analysis
Tafadzwa Dzinamarira, Grant Murewanhema, Itai Chitungo, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 6, pp. 654-661
Open Access | Times Cited: 29
Efficacy of COVID-19 Vaccination in People Living with HIV/AIDS in a Northern Brazil: Cross-Sectional Study
Carolinne de Jesus Santos e Santos, Ricardo Roberto de Souza Fonseca, Sandra Souza Lima, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 283-283
Open Access
Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities—An Agent-Based Modeling Evaluation
Beate Jahn, Gaby Sroczynski, Martin Bicher, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 434-434
Open Access | Times Cited: 39
Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection
Isabella Zanella, Daniela Zizioli, Francesco Castelli, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 454-454
Open Access | Times Cited: 38
Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition
Thandeka Nkosi, Caroline Chasara, Andrea Olga Papadopoulos, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 26
COVID-19 Burden on HIV Patients Attending Antiretroviral Therapy in Addis Ababa, Ethiopia: A Multicenter Cross-Sectional Study
Dagmawi Chilot, Yimtubezinash Woldeamanuel, Tsegahun Manyazewal
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 24
COVID‐19 vaccine acceptance among people living with HIV: A systematic review and meta‐analysis
Janet Yohannes Ejamo, Gebrehiwot Lema Legese, Yeabsira Aklilu Tesfaye, et al.
Tropical Medicine & International Health (2023) Vol. 28, Iss. 8, pp. 601-611
Open Access | Times Cited: 11
Co-Infections and Superinfections between HIV-1 and Other Human Viruses at the Cellular Level
Chiara Acchioni, Silvia Sandini, Marta Acchioni, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 349-349
Open Access | Times Cited: 3
Co-infection with coronavirus disease 2019, previously undiagnosed human immunodeficiency virus, Pneumocystis jirovecii pneumonia and cytomegalovirus pneumonitis, with possible immune reconstitution inflammatory syndrome
Elisabeth A. Merchant, Kristen Flint, Dan H. Barouch, et al.
IDCases (2021) Vol. 24, pp. e01153-e01153
Open Access | Times Cited: 25
Willingness to receive the COVID-19 vaccine among HIV positive men who have sex with men in China: a cross-sectional study
Songjie Wu, Shanhui Zhu, Xumeng Yan, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
HIV and SARS-CoV-2 infection in postpartum Kenyan women and their infants
Emily R. Begnel, Bhavna Chohan, Ednah Ojee, et al.
PLoS ONE (2023) Vol. 18, Iss. 1, pp. e0278675-e0278675
Open Access | Times Cited: 9
COVID-19 in-hospital mortality in South Africa: the intersection of communicable and non-communicable chronic diseases in a high HIV prevalence setting
Waasila Jassat, Cheryl Cohen, Maureen Masha, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 19
National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region
David Jilich, Agata Skrzat‐Klapaczyńska, Lukáš Fleischhans, et al.
HIV Medicine (2021) Vol. 23, Iss. 5, pp. 546-552
Open Access | Times Cited: 17
Fighting HIV-1 Persistence: At the Crossroads of “Shoc-K and B-Lock”
Chiara Acchioni, Enrico Palermo, Silvia Sandini, et al.
Pathogens (2021) Vol. 10, Iss. 11, pp. 1517-1517
Open Access | Times Cited: 17
Immune Response to COVID-19 and mRNA Vaccination in Immunocompromised Individuals: A Narrative Review
Norka I. Napuri, Daniel Curcio, David L. Swerdlow, et al.
Infectious Diseases and Therapy (2022) Vol. 11, Iss. 4, pp. 1391-1414
Open Access | Times Cited: 11
COVID-19 Vaccination Prioritization Strategies in Malaysia: A Retrospective Analysis of Early Evidence
Nor Elyzatul Akma Hamdan, Mathumalar Loganathan Fahrni, Antonio Ivan Lazzarino
Vaccines (2022) Vol. 11, Iss. 1, pp. 48-48
Open Access | Times Cited: 11
Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment
Luis Sarabia de Ardanaz, Jose M. Andreu-Ubero, Míriam Navidad-Fuentes, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 13
The likelihood of severe COVID‐19 outcomes among PLHIV with various comorbidities: a comparative frequentist and Bayesian meta‐analysis approach
Haoyi Wang, Kai J. Jonas
Journal of the International AIDS Society (2021) Vol. 24, Iss. 11
Open Access | Times Cited: 13
Perceived health-related quality of life in people living with HIV co-infected with SARS-CoV-2 in France
Yvenie Amboise, Issifou Yaya, Lisa Yombo-Kokule, et al.
Quality of Life Research (2024) Vol. 33, Iss. 9, pp. 2529-2539
Open Access | Times Cited: 1
Undiagnosed comorbidities among individuals hospitalised with COVID-19 in South African public hospitals
Waasila Jassat, Caroline Mudara, C Vika, et al.
South African Medical Journal (2022) Vol. 112, Iss. 9, pp. 747-752
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top